APA citiranje

Hanžel, J., Sever, N., Ferkolj, I., Štabuc, B., Smrekar, N., Kurent, T., . . . Drobne, D. (2019). Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease. United European Gastroenterol J.

Citação norma Chicago

Hanžel, Jurij, et al. "Early Vedolizumab Trough Levels Predict Combined Endoscopic and Clinical Remission in Inflammatory Bowel Disease." United European Gastroenterol J 2019.

MLA citiranje

Hanžel, Jurij, et al. "Early Vedolizumab Trough Levels Predict Combined Endoscopic and Clinical Remission in Inflammatory Bowel Disease." United European Gastroenterol J 2019.